Effects of N-terminal modification of recombinant human cytochrome P450 1A2 on catalytic activity

References

• Ahn K, Szczesna-Skorupa E, Kemper B. The amino-terminal 29 amino acids of cytochrome P450 2C1 are sufficient for retention in the endoplasmic reticulum. Journal of Biological Chemistry 1993; 268: 18726–18733
   PubMed Web of Science ®Google Scholar
• Bar-Nun S, Kreibich G, Adesnik M, Alterman L, Negish M, Sabatini DD. Synthesis and insertion of cytochrome P450 into endoplasmic reticulum membranes. Proceedings of the National Academy of Sciences. USA 1980; 77: 965–969
   Google Scholar
• Chang TKH, Waxman DJ. Methods in molecular biology. Cytochrome P450 protocols, IR Phillips, EA Shephard. Humana Press, New JerseyUSA 1998
   Google Scholar
• Coon MJ, Haugen DA, Guengerich FP, Vermilion JL, Dean WL. The structural basis of membrane function, Y Hatefi, L Djavadi-Ohanuance. Academic Press, New York 1976
   Google Scholar
• Dong MS, Yamazaki H, Guo Z, Guengerich FP. Recombinant human cytochrome P450 1A2 and an N-terminal-truncanted form: Construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase. Archives of Biochemistry and Biophysics 1996a; 327: 11–19
   PubMed Web of Science ®Google Scholar
• Dong MS, Bell LC, Guo Z, Phillops DR, Blair IA, Guengerich FP. Identification of retained N-fromylmethionine in bacterial recombinant mammalian cytochrome P450 proteins with the N-terminal sequence MALLLAVFL …: Roles of residues 3–5 in retention and membrane topology. Biochemisty 1996b; 35: 10031–10040
   PubMed Web of Science ®Google Scholar
• Estrabrook RW. The remarkable P450s: A historical overview of these versatile hemoprotein catalysts. Federation of American Societies for Experimental Biology Journal 1996; 10: 202–204
   PubMedGoogle Scholar
• Fiedbrg T, Pritchard MP, Bandera M, Hanlon SP, Yao D, McLaughlin LA, Ding S, Burchell B, Wolf CR. Merits and limitations of recombinant models for the study of human P450-mediated drug metabolism and toxicity: An intralaboratory comparison. Drug Metabolism Review 1999; 31: 523–544
   PubMedGoogle Scholar
• Gillam EM, Baba T, Kim BR, Ohmori S, Guengerich FP. Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme. Archives of Biochemistry and Biophysics 1993; 305: 123–131
   PubMed Web of Science ®Google Scholar
• Gillam EM, Guo Z, Guengerich FP. Expression of modified human cytochrome P450 2E1 in Escherichia coli, purification, and spectral and catalytic properties. Archives of Biochemistry and Biophysics 1994; 312: 59–66
   PubMed Web of Science ®Google Scholar
• Gonzalez FJ, Korzekwa KR. Cytochrome P450 expression systems. Annual Review of Pharmacology and Toxicology 1995; 35: 369–390
   PubMed Web of Science ®Google Scholar
• Guengerich FP. Catalytic selectivity of human cytochrome P450 enzymes: Relevance to drug metabolism and toxicity. Toxicology Letters 1994; 70: 133–138
   PubMed Web of Science ®Google Scholar
• Hanna IH, Kim MS, Guengerich FP. Heterologous expression of cytochrome P450 2D6 mutants, electron transfer, and catalysis of bufuralol hydroxylation: The role of aspartate 301 in structural integrity. Archives of Biochemistry and Biophysics 2001; 393: 255–261
   PubMed Web of Science ®Google Scholar
• Kim JS, Ahn T, Yim SK, Yun CH. Differential effect of copper(II) on the cytochrome P450 enzymes and NADPH-cytochrome P450 reductase: Inhibition of cytochrome P450-catalyzed reactions by copper(II) ion. Biochemistry 2002; 41: 9438–9447
   PubMed Web of Science ®Google Scholar
• Larson JR, Coon MJ, Ohkawa H. Purification and properties of a shortened form of cytochrome P450 2E1: Deletion of the NH2-terminal membrane-insertion signal peptide does not alter the catalytic activities. Proceedings of the National Academy of Sciences. USA 1991; 88: 9141–9145
   Google Scholar
• Lee HS, Jin C, Park J, Kim DH. Modulation of cytochrome P450 activities by 7,8-benzoflavone and its metabolites. Biochemistry and Molecular Biology 1994; 4: 483–491
   Google Scholar
• Macdonald TL, Gutheim WG, Martin RB, Guengerich FP. Oxidation of substituted N,N-dimethylanilines by cytochrome P-450: Estimation of the effective oxidation-reduction potential of cytochrome P-450. Biochemistry 1989; 28: 2071–2077
   PubMed Web of Science ®Google Scholar
• Miwa GT, Lu AY. The association of cytochrome P-450 and NADPH-cytochrome P-450 reductase in phospholipid membranes. Archives of Biochemistry and Biophysics 1984; 234: 161–166
   PubMed Web of Science ®Google Scholar
• Monier S, Van Luc P, Kreibich G, Sabatini DD, Adesnik M. Signals for the incorporation and orientation of cytochrome P450 in the endoplasmic reticulum membrane. Journal of Cell Biology 1988; 107: 457–470
   PubMed Web of Science ®Google Scholar
• Omura T, Sato R. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry 1964; 239: 2370–2378
   PubMed Web of Science ®Google Scholar
• Parikh A, Gillam EMJ, Guengerich FP. Drug metabolism by Esherichia coli expressing human cytochromes P450. Nature Biotechnology 1997; 15: 784–788
   PubMed Web of Science ®Google Scholar
• Sandhu P, Guo Z, Baba T, Martin MV, Tukey RH, Guengerich FP. Expression of modified human cytochrome P450 1A2 in Escherichia coli: Stabilization, purification, spectral characterization, and catalytic activities of the enzyme. Archives of Biochemistry and Biophysics 1994; 309: 168–177
   PubMed Web of Science ®Google Scholar
• Sato T, Sakaguchi M, Mihara K, Omura T. The amino-terminal structures that determine topological orientation of cytochrome P450 in microsomal membrane. European Molecular Biology Organization Journal 1990; 9: 2391–2397
   PubMed Web of Science ®Google Scholar
• Shen AL, Christensen MJ, Kasper CB. NADPH-cytochrome P-450 oxidoreductase. The role of cysteine 566 in catalysis and cofactor binding. Journal of Biological Chemistry 1991; 266: 19976–19980
   PubMedGoogle Scholar
• Shimada T, Tsumura F, Gillam EM, Guengerich FP, Inoue K. Roles of NADPH-P450 reductase in the O-deethylation of 7-ethoxycoumarin by recombinant human cytochrome P450 1B1 variants in Escherichia coli. Protein Expression and Purification 2000; 20: 73–80
   PubMed Web of Science ®Google Scholar
• Wachenfeldt CV, Johnson EF. Structures of eukaryotic cytochrome P450 enzymes in Cytochrome P450: Structure, mechanism, and biochemistry. 2nd ed, PRO de Montellano. Plenum Press, New York 1995
   Google Scholar
• Yamazaki H, Ueng YF, Shimada T, Guengerich FP. Roles of divalent metal ions in oxidations catalyzed by recombinant cytochrome P450 3A4 and replacement of NADPH-cytochrome P450 reductase with other flavoproteins, ferredoxin and oxygen surrogates. Biochemistry 1995; 34: 8380–8389
   PubMed Web of Science ®Google Scholar